Latest News in the pharma Industry

All

FDA approves Genentech’s Ocrevus for relapsing and primary progressive forms of MS

FDA approves Genentech’s Ocrevus for relapsing and primary progressive forms of MS

29 Mar 2017

An important new treatment option for people with relapsing forms of multiple sclerosis demonstrating superior efficacy on the three major markers of disease activity compared with Rebif.

Read more 
Tesaro announces FDA approval of Zejula for women with recurrent ovarian cancer

Tesaro announces FDA approval of Zejula for women with recurrent ovarian cancer

29 Mar 2017

US commercial launch planned for late April.

Read more 
Butterworth Labs to expand operations by 15%

Butterworth Labs to expand operations by 15%

29 Mar 2017

Part of a longer term plan to increase capacity.

Read more 
Merck introduces Mobius MyWay portfolio for customized single-use assemblies

Merck introduces Mobius MyWay portfolio for customized single-use assemblies

29 Mar 2017

Offers more flexibility, better supply predictability and shorter lead times for more efficient and safer drug manufacture.

Read more 
Analytical protein aggregate separation without a column

Analytical protein aggregate separation without a column

28 Mar 2017

System can achieve separations with higher resolution, reproducibility and recovery then has previously been possible.

Read more 
Chemotherapy as a tablet instead of an intravenous infusion

Chemotherapy as a tablet instead of an intravenous infusion

28 Mar 2017

New production method for solid dispersions of docetaxel and paclitaxel.

Read more 
Fiasp - a new, ultra-fast acting mealtime insulin

Fiasp - a new, ultra-fast acting mealtime insulin

28 Mar 2017

Canada first country to launch Fiasp.

Read more 
Regeneron and Sanofi announce FDA approval of Dupixent

Regeneron and Sanofi announce FDA approval of Dupixent

28 Mar 2017

First targeted biologic therapy for adults with moderate-to-severe atopic dermatitis.

Read more 
Encouraging results of Phase IIa study with Evenamide in patients with schizophrenia

Encouraging results of Phase IIa study with Evenamide in patients with schizophrenia

27 Mar 2017

Unique mechanism: glutamate modulation and voltage-gated sodium channel blockade.

Read more 
Eprex marketing authorisation extended to include treatment of symptomatic anaemia

Eprex marketing authorisation extended to include treatment of symptomatic anaemia

27 Mar 2017

French Health Authority ANSM grants approval in the Mutual Recognition Procedure; the relevant health authorities are required to implement the new indication within 30 days.

Read more 
Pfizer receives positive CHMP opinion for Trumenba for prevention of meningococcal group B disease

Pfizer receives positive CHMP opinion for Trumenba for prevention of meningococcal group B disease

27 Mar 2017

Trumenba has been studied in a global clinical development program evaluating the vaccine in adolescents and adults.

Read more 
Invivotek completes solar farm and facility expansion

Invivotek completes solar farm and facility expansion

27 Mar 2017

Provides a cleaner, renewable energy source to reduce costs and lessen the CRO facility's impact on the environment.

Read more